U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585149) titled 'Generating Intervals of Reference FFor Early Life Brain Biomarkers.' on April 21.
Brief Summary: Highly sensitive immunoassays for the detection of neuro-specific biomarkers are becoming more accessible. Currently, the majority of these biomarkers are detected with the use of labour-intensive and highly skilled wet lab work. However, recent advancements have allowed for the introduction of these neuro-specific biomarkers into mainstream clinical chemistry analysers, bringing them closer to clinical care. There is a vast amount of published literature for neuro-specific biomarkers in an adult and ageing population, unfortunately, the ...